BARDA Industry Day 2018 Presentations


clendar

October 29-30, 2018

8:00 AM to 5:00 PM Daily
check

Washington, D.C.

1000 H Street NW
doc

Printable Version

Print this page
BID18_Agenda_and_Breakout_Session

We are currently completing 508 compliance on all presentations that will be posted; however, please email us attechwatchinbox@hhs.gov to receive compliant files.

Day 1: Monday, October 29

Presentation
8:30-8:45

Welcome: Robert Kadlec, MD, MTM&H, MS

Assistant Secretary for Preparedness and Response

Presentation
8:45-9:10

Keynote Speaker: Steven H. Walker, PhD

Director, DARPA

Presentation
9:15-9:35

Leadership Perspective: ADM Brett Giroir (PDF - 1.3MB)

Assistant Secretary for Health

Presentation
9:40-9:55

Partner Perspective: Phil Gomez, PhD (PDF - 1.4MB)

CEO, SIGA Technologies, Inc.

Presentation
10:00-10:15

Partner Perspective: Gordon Naylor (PDF - 1.5MB)

President, Seqirus

Day 2: Tuesday, October 30

Presentation
8:45

Welcome Back: Rick Bright, PhD (PDF - 0.2MB)

BARDA Director

 

Presentation
9:00-9:30

Keynote Speaker: Martine Rothblatt, PhD, JD (PDF - 5.5MB)

CEO, United Therapeutics

 

Presentation
9:35-10:05

Conversation with Robert Kadlec, MD, MTM&H, MS (PDF - 0.1MB)

Assistant Secretary for Preparedness and Response

Moderator: Steve Brozak, DMH, MBA, CEO, WBB Securities

 

Presentation
10:05-10:25

BREAK - Meet & Greet with BARDA Director

Presentation
10:25-11:25

Venture Capital Perspectives: Panel Discussion (PDF - 0.5MB)

Patrick Heron, Managing General Partner, Frazier Healthcare Partners

Andrew Levin, MD, PhD, Managing Director, RA Capital Management

Ankit Mahadevia, MD, President & CEO, Spero Therapeutics

Moderator: Jay Lichter, PhD, Avalon Ventures

Presentation
11:30-12:00

Featured Speaker: Melinda Richter

Global Head, Johnson & Johnson Innovation, JLABS

12:00-1:00
LUNCH
TIME Session
Session
Session
1:00-2:00 DRIVe DoD/Collaborating on MCM Priorities Partnering with BARDA: TechWatch to BAA
2:00-2:15 Break/Networking Lounge
2:15-3:15 Perspectives in Pandemic Influenza Preparedness Developing Nonclinical Models with Partners BARDA Public-Private Partnership Case Studies
3:15-3:30 Break/Networking Lounge
3:30-4:30 Emergency Use Authorizations for MCMs in an Emergency FDA/Regulatory Considerations for MCM Development Repurposing for Chemical Medical Countermeasures

Presented By

DHHS Logo ASPR Logo BARDA Logo

Contact Us

Question or concerns:
email

Connect With Us

Website Refresh - www.medicalcountermeasures.gov is pleased to announce a phased launch of our newly redesigned public website. We are making website improvements to provide a more modern and customer-centric web experience. Over the next several months you will see differences throughout the site while we continue implementing updates. Thank you for your understanding and please let us know if you have any questions: techwatchinbox@hhs.gov